Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 6/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | ALPL | P05186 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.32 |
| ▸ | GRK5 | P34947 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2458220 | 0.78 | PKM (0.44) | PKMKDM4EMAPTSMN1; SMN2HTT | |
| SCHEMBL28507244 | 0.78 | PKM (0.32) | PKMLMNA | |
| SCHEMBL7778311 | 0.76 | PKM (0.35) | PKMKDM4EMAPTSMN1; SMN2HTT | |
| SCHEMBL30724548 | 0.76 | PKM (0.32) | PKM | |
| SCHEMBL28848233 | 0.76 | ALDH1A1 (0.43) | PKMKDM4EMAPTSMN1; SMN2HTT | |
| SCHEMBL18420239 | 0.74 | LMNA (0.35) | PKMSMN1; SMN2ALDH1A1LMNAATM | |
| SCHEMBL7778351 | 0.73 | ALDH1A1 (0.42) | PKMKDM4EMAPTSMN1; SMN2HTT | |
| SCHEMBL28903969 | 0.72 | LMNA (0.33) | ALDH1A1LMNAATML3MBTL1 | |
| SCHEMBL29091845 | 0.72 | — | — | |
| SCHEMBL28849782 | 0.71 | L3MBTL1 (0.38) | MAPTSMN1; SMN2HTTPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118619882-A | Synthesis method of 1-methyl-3, 4, 5-trinitropyrazole MTNP | 中北大学 | 2024-09-10 | — | — | CN | claimed |
| CN-120118035-A | Synthesis method of 1-methyl-3, 4, 5-trinitropyrazole | 西南科技大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-118619882-A | Synthesis method of 1-methyl-3, 4, 5-trinitropyrazole MTNP | 中北大学 | 2024-09-10 | — | — | CN | disclosed |
| CN-118619882-A | Synthesis method of 1-methyl-3, 4, 5-trinitropyrazole MTNP | 中北大学 | 2024-09-10 | — | — | CN | disclosed |
| US-8440839-B2 | Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them | HERAKLES (FR) | 2013-05-14 | — | — | US | disclosed |
| US-20120323017-A1 | DINITROPYRAZOLE DERIVATIVES, THEIR PREPARATION, AND ENERGETIC COMPOSITIONS COMPRISING THEM | EURENCO (FR) | 2012-12-20 | — | — | US | disclosed |
| EP-0786244-B1 | Oxidation hair-dye comprising 3,4,5 triaminopyrazole derivatives, and novel 3,4,5 triaminopyrazole derivatives | WELLA AG (DE) | 2001-09-19 | — | — | EP | disclosed |
| US-5766576-A | NONTOXIC DYE DEVELOPER; WASHFASTNESS, COLORFASTNESS, RED COLOR INTENSITY | WELLA AKTIENGESELLSCHAFT (DE) | 1998-06-16 | — | — | US | disclosed |
| EP-0786244-A1 | Oxidation hair-dye comprising 3,4,5 triaminopyrazole derivatives, and novel 3,4,5 triaminopyrazole derivatives | Wella Aktiengesellschaft (DE) | 1997-07-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120323017-A1 | DINITROPYRAZOLE DERIVATIVES, THEIR PREPARATION, AND ENERGETIC COMPOSITIONS COMPRISING THEM | NFE2L2, NFE2, RELA | PKM 1669/4885KDM4E 3291/4885MAPT 3354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.